178 related articles for article (PubMed ID: 22922976)
1. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.
Kim YC; Camaioni E; Ziganshin AU; Ji XD; King BF; Wildman SS; Rychkov A; Yoburn J; Kim H; Mohanram A; Harden TK; Boyer JL; Burnstock G; Jacobson KA
Drug Dev Res; 1998 Oct; 45(2):52-66. PubMed ID: 22922976
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
[TBL] [Abstract][Full Text] [Related]
3. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
Fischer B; Boyer JL; Hoyle CH; Ziganshin AU; Brizzolara AL; Knight GE; Zimmet J; Burnstock G; Harden TK; Jacobson KA
J Med Chem; 1993 Nov; 36(24):3937-46. PubMed ID: 8254622
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
Bültmann R; Dudeck O; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):445-51. PubMed ID: 8935712
[TBL] [Abstract][Full Text] [Related]
5. Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X Receptors.
Brown SG; King BF; Kim YC; Jang SY; Burnstock G; Jacobson KA
Drug Dev Res; 2000 Apr; 49(4):253-259. PubMed ID: 22791931
[TBL] [Abstract][Full Text] [Related]
6. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
[TBL] [Abstract][Full Text] [Related]
7. Design and pharmacology of selective P2-purinoceptor antagonists.
Lambrecht G
J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
[TBL] [Abstract][Full Text] [Related]
8. The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.
Lambrecht G; Rettinger J; Bäumert HG; Czeche S; Damer S; Ganso M; Hildebrandt C; Niebel B; Spatz-Kümbel G; Schmalzing G; Mutschler E
Eur J Pharmacol; 2000 Jan; 387(3):R19-21. PubMed ID: 10650184
[TBL] [Abstract][Full Text] [Related]
9. Actions of a Series of PPADS Analogs at P2X
Brown SG; Kim YC; Kim SA; Jacobson KA; Burnstock G; King BF
Drug Dev Res; 2001 Aug; 53(4):281-291. PubMed ID: 27134334
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.
Windscheif U; Pfaff O; Ziganshin AU; Hoyle CH; Bäumert HG; Mutschler E; Burnstock G; Lambrecht G
Br J Pharmacol; 1995 Aug; 115(8):1509-17. PubMed ID: 8564212
[TBL] [Abstract][Full Text] [Related]
11. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor.
Kim YC; Lee JS; Sak K; Marteau F; Mamedova L; Boeynaems JM; Jacobson KA
Biochem Pharmacol; 2005 Jul; 70(2):266-74. PubMed ID: 15913566
[TBL] [Abstract][Full Text] [Related]
13. Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y(1) receptor antagonists.
Kim YC; Gallo-Rodriguez C; Jang SY; Nandanan E; Adams M; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2000 Feb; 43(4):746-55. PubMed ID: 10691699
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.
Jung KY; Cho JH; Lee JS; Kim HJ; Kim YC
Bioorg Med Chem; 2013 May; 21(9):2643-50. PubMed ID: 23510563
[TBL] [Abstract][Full Text] [Related]
15. P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2.
Tuluc F; Bültmann R; Glänzel M; Frahm AW; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):111-20. PubMed ID: 9521483
[TBL] [Abstract][Full Text] [Related]
16. In search of selective P2 receptor ligands: interaction of dihydropyridine derivatives at recombinant rat P2X(2) receptors.
Jacobson KA; Kim YC; King BF
J Auton Nerv Syst; 2000 Jul; 81(1-3):152-7. PubMed ID: 10869714
[TBL] [Abstract][Full Text] [Related]
17. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells.
Ohtani M; Ohura K; Oka T
Cell Physiol Biochem; 2011; 28(2):355-66. PubMed ID: 21865744
[TBL] [Abstract][Full Text] [Related]
18. ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens.
Queiroz G; Talaia C; Gonçalves J
J Pharmacol Exp Ther; 2003 Nov; 307(2):809-15. PubMed ID: 12966150
[TBL] [Abstract][Full Text] [Related]
19. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
Xu B; Stephens A; Kirschenheuter G; Greslin AF; Cheng X; Sennelo J; Cattaneo M; Zighetti ML; Chen A; Kim SA; Kim HS; Bischofberger N; Cook G; Jacobson KA
J Med Chem; 2002 Dec; 45(26):5694-709. PubMed ID: 12477353
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ecto-Apyrase and Ecto-ATPase by Pyridoxal Phosphate-Related Compounds.
Hoffmann C; Heine P; Pradel G; Kim YC; Jacobson KA; Zimmermann H
Drug Dev Res; 2000 Nov; 51(3):151-158. PubMed ID: 27134333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
